BRAF and Miyoshi myopathy: KRAS, NRAS and BRAF mutations are detectable in up to 50% of newly diagnosed MM patients.3 The incidence of mutations in most other genes is much lower, indicating the importance of the deregulation of key pathways, rather than mutations in single genes.